Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved

Aims Renal function (estimated glomerular filtration rate [eGFR]) changes early after the introduction of empagliflozin have not been described in heart failure with preserved ejection fraction (HFpEF). The aim of this study was to describe early eGFR changes, assess its determinants and its clinica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rastogi, Tripti (VerfasserIn) , Ferreira, João Pedro (VerfasserIn) , Butler, Javed (VerfasserIn) , Kraus, Bettina Johanna (VerfasserIn) , Mattheus, Michaela (VerfasserIn) , Brückmann, Martina (VerfasserIn) , Filippatos, Gerasimos (VerfasserIn) , Wanner, Christoph (VerfasserIn) , Pocock, Stuart J. (VerfasserIn) , Packer, Milton (VerfasserIn) , Anker, Stefan D. (VerfasserIn) , Zannad, Faiez (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 January 2024
In: European journal of heart failure
Year: 2024, Jahrgang: 26, Heft: 4, Pages: 885-896
ISSN:1879-0844
DOI:10.1002/ejhf.3136
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ejhf.3136
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ejhf.3136
Volltext
Verfasserangaben:Tripti Rastogi, João Pedro Ferreira, Javed Butler, Bettina Johanna Kraus, Michaela Mattheus, Martina Brueckmann, Gerasimos Filippatos, Christoph Wanner, Stuart J. Pocock, Milton Packer, Stefan D. Anker, and Faiez Zannad

MARC

LEADER 00000caa a22000002c 4500
001 1888374497
003 DE-627
005 20260107141151.0
007 cr uuu---uuuuu
008 240513s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/ejhf.3136  |2 doi 
035 |a (DE-627)1888374497 
035 |a (DE-599)KXP1888374497 
035 |a (OCoLC)1443678405 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rastogi, Tripti  |e VerfasserIn  |0 (DE-588)1329168836  |0 (DE-627)1888375434  |4 aut 
245 1 0 |a Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved  |c Tripti Rastogi, João Pedro Ferreira, Javed Butler, Bettina Johanna Kraus, Michaela Mattheus, Martina Brueckmann, Gerasimos Filippatos, Christoph Wanner, Stuart J. Pocock, Milton Packer, Stefan D. Anker, and Faiez Zannad 
264 1 |c 21 January 2024 
300 |b Illustrationen 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Vorab veröffentlicht: 21. Januar 2024 
500 |a Gesehen am 13.05.2024 
520 |a Aims Renal function (estimated glomerular filtration rate [eGFR]) changes early after the introduction of empagliflozin have not been described in heart failure with preserved ejection fraction (HFpEF). The aim of this study was to describe early eGFR changes, assess its determinants and its clinical impact on cardiovascular and renal outcomes in patients with HFpEF enrolled in EMPEROR-Preserved. Methods and results Estimated glomerular filtration rate changes (absolute and relative) from randomization to week 4 were calculated and landmark analyses performed. Initial eGFR change was available in 5836 patients (97.5% of the population). Empagliflozin induced a mean eGFR change of −3.2 ml/min/1.73 m2 versus placebo from baseline to week 4. After week 4, in the empagliflozin group, the risk of the primary outcome (composite of heart failure hospitalization or cardiovascular death), cardiovascular, all-cause mortality and sustained ≥50% eGFR decrease or end-stage renal disease (ESRD) did not differ by eGFR change levels. In contrast, in the placebo group, patients included in the tertile with most profound eGFR decrease (i.e. ≥5.1% from baseline) had a higher risk of the primary outcome (hazard ratio [HR] 1.46, 95% confidence interval [CI] 1.17-1.82), cardiovascular mortality (HR 1.38, 95% CI 1.01-1.89) and sustained ≥50% eGFR decrease or ESRD (HR 2.20, 95% CI 1.20-4.04) versus tertile with eGFR increase. Conclusion An initial relatively small eGFR decrease may be expected after empagliflozin initiation. Such small eGFR decrease was not associated with adverse cardiovascular outcomes with empagliflozin. In contrast, eGFR decrease was associated with poor cardiovascular outcomes with placebo. 
650 4 |a Cardiovascular and renal outcomes 
650 4 |a Empagliflozin 
650 4 |a Estimated glomerular filtration rate changes 
650 4 |a Heart failure with preserved ejection fraction 
700 1 |a Ferreira, João Pedro  |e VerfasserIn  |4 aut 
700 1 |a Butler, Javed  |e VerfasserIn  |4 aut 
700 1 |a Kraus, Bettina Johanna  |e VerfasserIn  |4 aut 
700 1 |a Mattheus, Michaela  |e VerfasserIn  |4 aut 
700 1 |a Brückmann, Martina  |d 1970-  |e VerfasserIn  |0 (DE-588)121145069  |0 (DE-627)705257290  |0 (DE-576)292557736  |4 aut 
700 1 |a Filippatos, Gerasimos  |e VerfasserIn  |4 aut 
700 1 |a Wanner, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Pocock, Stuart J.  |e VerfasserIn  |4 aut 
700 1 |a Packer, Milton  |e VerfasserIn  |4 aut 
700 1 |a Anker, Stefan D.  |e VerfasserIn  |4 aut 
700 1 |a Zannad, Faiez  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of heart failure  |d Oxford : Oxford University Press, 1999  |g 26(2024), 4, Seite 885-896  |h Online-Ressource  |w (DE-627)306658291  |w (DE-600)1500332-2  |w (DE-576)081985983  |x 1879-0844  |7 nnas  |a Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved 
773 1 8 |g volume:26  |g year:2024  |g number:4  |g pages:885-896  |g extent:12  |a Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved 
856 4 0 |u https://doi.org/10.1002/ejhf.3136  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ejhf.3136  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20240513 
993 |a Article 
994 |a 2024 
998 |g 121145069  |a Brückmann, Martina  |m 121145069:Brückmann, Martina  |d 60000  |d 61000  |e 60000PB121145069  |e 61000PB121145069  |k 0/60000/  |k 1/60000/61000/  |p 6 
999 |a KXP-PPN1888374497  |e 4522203942 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Vorab veröffentlicht: 21. Januar 2024","Gesehen am 13.05.2024"],"title":[{"title_sort":"Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved","title":"Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved"}],"person":[{"family":"Rastogi","display":"Rastogi, Tripti","roleDisplay":"VerfasserIn","given":"Tripti","role":"aut"},{"display":"Ferreira, João Pedro","family":"Ferreira","roleDisplay":"VerfasserIn","role":"aut","given":"João Pedro"},{"family":"Butler","display":"Butler, Javed","roleDisplay":"VerfasserIn","given":"Javed","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Kraus","display":"Kraus, Bettina Johanna","given":"Bettina Johanna","role":"aut"},{"role":"aut","given":"Michaela","roleDisplay":"VerfasserIn","family":"Mattheus","display":"Mattheus, Michaela"},{"given":"Martina","role":"aut","roleDisplay":"VerfasserIn","display":"Brückmann, Martina","family":"Brückmann"},{"role":"aut","given":"Gerasimos","roleDisplay":"VerfasserIn","display":"Filippatos, Gerasimos","family":"Filippatos"},{"given":"Christoph","role":"aut","roleDisplay":"VerfasserIn","family":"Wanner","display":"Wanner, Christoph"},{"role":"aut","given":"Stuart J.","roleDisplay":"VerfasserIn","display":"Pocock, Stuart J.","family":"Pocock"},{"roleDisplay":"VerfasserIn","display":"Packer, Milton","family":"Packer","given":"Milton","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Anker, Stefan D.","family":"Anker","given":"Stefan D.","role":"aut"},{"display":"Zannad, Faiez","family":"Zannad","roleDisplay":"VerfasserIn","role":"aut","given":"Faiez"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"id":{"eki":["1888374497"],"doi":["10.1002/ejhf.3136"]},"physDesc":[{"extent":"12 S.","noteIll":"Illustrationen"}],"recId":"1888374497","name":{"displayForm":["Tripti Rastogi, João Pedro Ferreira, Javed Butler, Bettina Johanna Kraus, Michaela Mattheus, Martina Brueckmann, Gerasimos Filippatos, Christoph Wanner, Stuart J. Pocock, Milton Packer, Stefan D. Anker, and Faiez Zannad"]},"relHost":[{"part":{"volume":"26","pages":"885-896","year":"2024","text":"26(2024), 4, Seite 885-896","issue":"4","extent":"12"},"origin":[{"publisherPlace":"Oxford ; Amsterdam [u.a.] ; Oxford [u.a.] ; Oxford","dateIssuedKey":"1999","publisher":"Oxford University Press ; Elsevier Science ; Oxford Univ. Press ; Wiley","dateIssuedDisp":"1999-"}],"pubHistory":["1.1999 -"],"disp":"Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-PreservedEuropean journal of heart failure","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 07.01.25"],"title":[{"title_sort":"European journal of heart failure","title":"European journal of heart failure","subtitle":"journal of the Working Group on Heart Failure of the European Society of Cardiology"}],"recId":"306658291","titleAlt":[{"title":"EJHF"}],"id":{"zdb":["1500332-2"],"issn":["1879-0844"],"eki":["306658291"],"doi":["10.1002/(ISSN)1879-0844"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedDisp":"21 January 2024","dateIssuedKey":"2024"}]} 
SRT |a RASTOGITRIEARLYCHANG2120